"Revolutionizing Cancer Genomics: Reflecting on 15 Years of Progress"

Fifteen years ago, the first complete genome of a cancer, specifically acute myeloid leukemia (AML), was reported, leading to significant advancements in molecular diagnostics, prognostics, and therapeutics. The genomic data sets generated since then have revolutionized our understanding of tumor biology.